Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6,264 INR
Change Today +125.75 / 2.05%
Volume 14.5K
SKB On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
6,185
Previous Close
6,139
Day High
6,306
Day Low
6,007
52 Week High
04/15/15 - 6,575
52 Week Low
09/19/14 - 4,900
Market Cap
263.4B
Average Volume 10 Days
11.9K
EPS TTM
144.67
Shares Outstanding
42.1M
EX-Date
07/27/15
P/E TM
43.3x
Dividend
55.00
Dividend Yield
0.88%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. The company manufactures and markets nutritional supplements, biscuits, and malt-based and chocolate health food drinks under the Horlicks, Boost, Maltova, and Viva brand names. It also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, the company provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. Further, it offers its products under the Voltaren, Theraflu, Paradontax, Panadol, Polident, Otrivin, and Physiogel brands. The company exports its products to Bangladesh, Sri Lanka, Bhutan, the Middle East, Myanmar, and Pakistan. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,527 Employees
Last Reported Date: 07/10/15
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Director of Operations, Wholetime Director an...
Total Annual Compensation: 18.1M
Compliance Officer, General Manager of Legal ...
Total Annual Compensation: 5.2M
Compensation as of Fiscal Year 2015.

glaxosmithkline consumer hea (SKB) Key Developments

Glaxosmithkline Consumer Healthcare Limited Reports Unaudited Standalone Earnings Results for the Second Quarter Ended June 30, 2015

GlaxoSmithKline Consumer Healthcare Limited reported unaudited standalone earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported net sales/income from operations of INR 9,903.1 million against INR 9,215.5 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,835.4 million against INR 1,527.3 million for the same period a year ago. Profit from ordinary activities before tax was INR 2,382.5 million against INR 1,983.0 million for the same period a year ago. Net profit for the period was INR 1,550.1 million against INR 1,301.2 million for the same period a year ago. Basic and diluted earnings per share (before and after extraordinary items) were INR 36.85 against INR 30.94 per share a year ago.

GlaxoSmithKline Consumer Healthcare Limited, Board Meeting, Aug 05, 2015

GlaxoSmithKline Consumer Healthcare Limited, Board Meeting, Aug 05, 2015. Agenda: To consider and take on record the un-audited financial results for the quarter ended June 30, 2015 with limited review done by the statutory auditors.

GlaxoSmithKline Consumer Healthcare Limited to Report Q1, 2016 Results on Aug 05, 2015

GlaxoSmithKline Consumer Healthcare Limited announced that they will report Q1, 2016 results on Aug 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 6,264.25 INR +125.75

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $2.71 USD +0.06
DC Brands International Inc $0.0001 USD 0.00
Perrigo Co PLC $185.42 USD -2.77
VIVUS Inc $1.15 USD +0.04
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 41.5x
Price/Sales 5.8x
Price/Book 12.0x
Price/Cash Flow 37.5x
TEV/Sales 5.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.